Product Information

CELECOXIB 50 MG CAPSULE is a generic product labeled by Actavis Pharma, Inc., priced at $0.0812 per EA under NDC 00591398260. Its NADAC has been published 574 times since May 20, 2015.

FDA first approved this application on Feb 11, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CELECOXIB 50 MG CAPSULE

Celecoxib
$0.0812per EA

Strength

50 mg/1

NDC

00591398260

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

CELECOXIB

Approval Type

Generic (ANDA)

FDA Application

ANDA200562

FDA Approved

2/11/2015

TE Code

AB

On Market Since

3/12/2015

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for CELECOXIB 50 MG CAPSULE has been published 574 times since May 20, 2015, and over the history we have for it it has declined 85.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0812 per EA
All-time high$0.5704 (Jul 15, 2015)
All-time low$0.0492 (Nov 20, 2024)
52-week high$0.1073
52-week low$0.0812
Median price$0.1769
Average price$0.2162
Largest weekly change+128.0% (Jan 19, 2022)
Weeks tracked574
Tracking sinceMay 20, 2015

Price History

1W

0.0%

1M

-11.2%

3M

-0.6%

6M

-18.5%

1Y

-5.0%

3Y

-14.5%

5Y

-56.7%

All

-85.7%

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CELECOXIB 50 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for CELECOXIB 50 MG CAPSULE, manufactured by Actavis Pharma, Inc., is $0.0812 per EA (NDC 00591398260), effective Nov 11, 2026.

How has the price of CELECOXIB 50 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for CELECOXIB 50 MG CAPSULE has declined 85.7%. It has been tracked across 574 weekly CMS publications since May 20, 2015.

What are the highest and lowest recorded NADAC prices for CELECOXIB 50 MG CAPSULE?

Since May 20, 2015, the NADAC for CELECOXIB 50 MG CAPSULE has ranged from a low of $0.0492 (Nov 20, 2024) to a high of $0.5704 (Jul 15, 2015), with a median of $0.1769 per EA.

Are there cheaper alternatives to CELECOXIB 50 MG CAPSULE?

9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CELECOXIB 50 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures CELECOXIB 50 MG CAPSULE?

CELECOXIB 50 MG CAPSULE (NDC 00591398260) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.